Monday , December 10 2018
Breaking News
Home / BUSINESS / Cadila Healthcare’s Biologics manufacturing facility gets EIR from USFDA

Cadila Healthcare’s Biologics manufacturing facility gets EIR from USFDA

Cadila Healthcare’s Biologics manufacturing facility (Zydus Biologics) located at Ahmedabad has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) signifying the successful closure of the audit from August 14 to August 24, 2018, with zero 483 observations.

Cadila Healthcare is an India-based pharmaceutical company. The company’s subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Loading...

Leave a Reply

Your email address will not be published. Required fields are marked *

*